Bioscience Animal Health PCL (BKK:BIS)

Market Cap	624.86M -22.9%
Revenue (ttm)	2.25B -3.0%
Net Income	38.47M -40.8%
EPS	0.12 -40.8%
Shares Out	314.00M
PE Ratio	16.24
Forward PE	n/a
Dividend	0.12 (6.03%)
Ex-Dividend Date	Apr 29, 2026

Volume	8,101
Average Volume	21,205
Open	2.000
Previous Close	1.970
Day's Range	1.980 - 2.000
52-Week Range	1.700 - 3.120
Beta	0.56
RSI	47.44
Earnings Date	May 12, 2026

About BKK:BIS

Bioscience Animal Health Public Company Limited, together with its subsidiaries, manufactures, imports, and distributes pharmaceutical supplies, devices, equipment, and products for livestock and companion animals in Thailand and internationally. The company offers antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. In addition, the company offers farm production consultant; disease prevention a...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2004
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BIS

Financial Performance

In 2025, BKK:BIS's revenue was 2.25 billion, a decrease of -3.01% compared to the previous year's 2.32 billion. Earnings were 38.47 million, a decrease of -40.85%.